Edgewood Oncology raised $20 million in Series A financing backed by Alta Partners to advance BTX-A51 in patients with hematologic malignancies and genetically-defined solid tumors.
Amount Raised
$20 Million
Round Type
Series A
BrooklineBiotechnologyInvestors
Description
Edgewood Oncology emerged from stealth with $20 million in Series A financing to advance the clinical development of BTX-A51 in acute myeloid leukemia (AML) and a precision medicine approach to breast cancer. The company acquired the rights to BTX-A51 from Yissum, the technology transfer company of The Hebrew University of Jerusalem, and will use the funding to advance efficacy studies in AML and breast cancer.
Quick answer
Edgewood Oncology raised $20 Million in a Series A round, dated March 25, 2024. Investors: Alta Partners. Edgewood Oncology is based in Brookline, Massachusetts, United States.
- How much did Edgewood Oncology raise?
- Edgewood Oncology raised $20 Million in a Series A round on March 25, 2024.
- Who invested in Edgewood Oncology?
- Alta Partners is named as investors in this round.
- What does Edgewood Oncology do?
- Edgewood Oncology is a clinical-stage biotechnology company that was founded to deliver on the promise of BTX-A51 for patients with hematologic malignancies and genetically-defined solid tumors.
- Where is Edgewood Oncology based and how big is it?
- Edgewood Oncology is based in Brookline, Massachusetts, United States.
- Who are the decision-makers at Edgewood Oncology?
- Fundz holds 1 contact at Edgewood Oncology. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Edgewood Oncology that raised within 45 days of this round, from Fundz verified event records.
- Elegen raised $33M on May 9, 2024.
- R3 Vascular raised $87M (Series B) on May 9, 2024.
- Alzamend Neuro raised $25M (Series A) on May 9, 2024.
- Eledon raised $50M on May 9, 2024.
- Aardvark Therapeutics raised $85M (Series C) on May 9, 2024.
- Frequency Exchange raised $210K (Pre-Seed) on May 9, 2024.
Who to call at Edgewood Oncology, and when
A new round usually means Edgewood Oncology is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Edgewood Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Edgewood Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Edgewood Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Edgewood Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEdgewood Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.